← Back to browse
S 1157 Passed a chamber

Directs the Health and Human Services Secretary to review federal lung cancer research, prevention, and treatment programs with a focus on women and people with few known risk factors, and to report the findings to Congress within two years.

Official title: Women and Lung Cancer Research and Preventive Services Act of 2025

Next stop House: awaiting action
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Received 09-JUN-2026
Senate
Introduced 26-MAR-2025
Referred 26-MAR-2025
Approved by committee 15-JAN-2026
Reported 28-JAN-2026
On the calendar 28-JAN-2026
Passed 08-JUN-2026
Key points
  • Requires HHS, consulting with the Defense and Veterans Affairs secretaries, to review and update federal lung cancer programs and strategic plans.
  • Focuses on knowledge gaps for women and people with few known risk factors, and on raising screening rates among groups the U.S. Preventive Services Task Force recommends for screening.
  • Covers possible research on environmental and genomic factors, biomarker testing, and the need for public awareness and education.
  • Requires a report to the Senate and House health, appropriations, and commerce committees within two years of enactment, describing changes made and barriers to further changes.
AI-generated from the Engrossed in Senate text of 08-JUN-2026 · verify · report an error
Official CRS summary

No CRS summary yet. CRS writes one for most bills, often months after they move.

CRS is the Library of Congress's nonpartisan research office. Check on congress.gov
Committee referrals (1) Policy area

Health

Sponsor Tina Smith (D-MN) Cosponsors · 7
■ 5 D■ 2 R